6.
Durand J, Cretel E, Retornaz F, Lefevre P, Kaplanski G, Soubeyrand J
. Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection. J Hepatol. 1994; 21(2):277-8.
DOI: 10.1016/s0168-8278(05)80409-x.
View
7.
Kosugi S, Tomiyama Y, Shiraga M, Kashiwagi H, Mizutani H, Kanakura Y
. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies. Thromb Haemost. 1996; 75(2):339-45.
View
8.
Goulis J, Chau T, Jordan S, Mehta A, Watkinson A, Rolles K
. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut. 1999; 44(5):754-8.
PMC: 1727482.
DOI: 10.1136/gut.44.5.754.
View
9.
Wang C, Yao W, Wang S, Chang T, Chou P
. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin Infect Dis. 2004; 39(6):790-6.
DOI: 10.1086/423384.
View
10.
Leroy V, Arvieux J, Jacob M, Maynard-Muet M, Baud M, Zarski J
. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol. 1998; 101(3):468-74.
DOI: 10.1046/j.1365-2141.1998.00722.x.
View
11.
Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N
. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol. 2003; 18(6):638-44.
DOI: 10.1046/j.1440-1746.2003.03026.x.
View
12.
Kosugi S, Imai Y, Kurata Y, Tomiyama Y, Shiraga M, Honda S
. Platelet-associated IgM elevated in patients with chronic hepatitis C contains no anti-platelet autoantibodies. Liver. 1997; 17(5):230-7.
DOI: 10.1111/j.1600-0676.1997.tb01023.x.
View
13.
Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud M, Trepo C
. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood. 1998; 91(10):3841-9.
View
14.
Linares M, Pastor E, Hernandez F, Montagud M, Blanquer A
. Autoimmune thrombocytopenia and hepatitis C virus infection. Am J Hematol. 1996; 53(4):284.
DOI: 10.1002/(SICI)1096-8652(199612)53:4<284::AID-AJH20>3.0.CO;2-B.
View
15.
Pivetti S, Novarino A, Merico F, Bertero M, Brunetto M, Bonino F
. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol. 1996; 95(1):204-11.
DOI: 10.1046/j.1365-2141.1996.7542376.x.
View
16.
Fried M, Shiffman M, Reddy K, Smith C, Marinos G, Goncales Jr F
. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002; 347(13):975-82.
DOI: 10.1056/NEJMoa020047.
View
17.
George J
. Platelets. Lancet. 2000; 355(9214):1531-9.
DOI: 10.1016/S0140-6736(00)02175-9.
View
18.
de Almeida A, Campos-de-Magalhaes M, de Melo Marcal O, Brandao-Mello C, Okawa M, de Oliveira R
. Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. Ann Hematol. 2004; 83(7):434-40.
DOI: 10.1007/s00277-004-0844-0.
View
19.
Bordin G, Ballare M, Zigrossi P, Bertoncelli M, Paccagnino L, Baroli A
. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?. Clin Exp Rheumatol. 1995; 13 Suppl 13:S39-43.
View
20.
Bauduer F, Marty F, Larrouy M, Ducout L
. Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection. Am J Hematol. 1998; 57(4):338-40.
DOI: 10.1002/(sici)1096-8652(199804)57:4<338::aid-ajh12>3.0.co;2-4.
View